 Brent Palmer
Concepts (451)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD4-Positive T-Lymphocytes | 34 | 2021 | 965 | 3.680 |
Why?
| | HIV Infections | 35 | 2022 | 2470 | 3.600 |
Why?
| | Gastrointestinal Microbiome | 6 | 2024 | 502 | 1.920 |
Why?
| | Homosexuality, Male | 4 | 2022 | 170 | 1.600 |
Why?
| | HIV-1 | 17 | 2018 | 768 | 1.570 |
Why?
| | Sexual and Gender Minorities | 4 | 2022 | 138 | 1.570 |
Why?
| | Microbiota | 7 | 2022 | 648 | 1.500 |
Why?
| | HIV | 5 | 2019 | 208 | 1.380 |
Why?
| | Programmed Cell Death 1 Receptor | 11 | 2019 | 193 | 1.240 |
Why?
| | Dysbiosis | 3 | 2021 | 146 | 1.030 |
Why?
| | Virus Replication | 5 | 2010 | 393 | 1.010 |
Why?
| | CD8-Positive T-Lymphocytes | 16 | 2021 | 691 | 0.950 |
Why?
| | Epitopes, T-Lymphocyte | 6 | 2010 | 170 | 0.950 |
Why?
| | Lymphocyte Activation | 16 | 2018 | 1042 | 0.940 |
Why?
| | Receptors, CCR5 | 4 | 2021 | 54 | 0.940 |
Why?
| | Feces | 4 | 2021 | 373 | 0.900 |
Why?
| | Antigens, CD | 9 | 2020 | 441 | 0.820 |
Why?
| | Berylliosis | 6 | 2013 | 177 | 0.800 |
Why?
| | Gastrointestinal Tract | 2 | 2014 | 169 | 0.780 |
Why?
| | Viral Load | 9 | 2020 | 405 | 0.770 |
Why?
| | Firmicutes | 1 | 2021 | 17 | 0.740 |
Why?
| | Macrophages, Alveolar | 3 | 2020 | 351 | 0.730 |
Why?
| | Anti-Inflammatory Agents | 3 | 2022 | 451 | 0.710 |
Why?
| | Antiretroviral Therapy, Highly Active | 7 | 2016 | 256 | 0.700 |
Why?
| | T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2020 | 7 | 0.700 |
Why?
| | Up-Regulation | 9 | 2019 | 812 | 0.690 |
Why?
| | Inflammation | 7 | 2022 | 2485 | 0.670 |
Why?
| | Germ-Free Life | 1 | 2019 | 30 | 0.660 |
Why?
| | Varicellovirus | 4 | 2022 | 26 | 0.630 |
Why?
| | Leukocytes, Mononuclear | 7 | 2022 | 496 | 0.630 |
Why?
| | Apoptosis Regulatory Proteins | 3 | 2008 | 172 | 0.630 |
Why?
| | T-Lymphocyte Subsets | 10 | 2016 | 383 | 0.590 |
Why?
| | Anti-HIV Agents | 5 | 2016 | 668 | 0.580 |
Why?
| | CD57 Antigens | 3 | 2007 | 15 | 0.570 |
Why?
| | B7-H1 Antigen | 6 | 2019 | 139 | 0.560 |
Why?
| | Beryllium | 6 | 2009 | 146 | 0.550 |
Why?
| | Cytokines | 12 | 2021 | 1843 | 0.550 |
Why?
| | Lung | 16 | 2022 | 3595 | 0.540 |
Why?
| | Interferon-gamma | 13 | 2013 | 723 | 0.540 |
Why?
| | Intestinal Mucosa | 1 | 2021 | 528 | 0.530 |
Why?
| | Bacteria | 4 | 2022 | 728 | 0.510 |
Why?
| | Cord Blood Stem Cell Transplantation | 1 | 2016 | 91 | 0.500 |
Why?
| | Humans | 83 | 2024 | 115038 | 0.500 |
Why?
| | Viremia | 5 | 2018 | 122 | 0.490 |
Why?
| | T-Lymphocytes, Regulatory | 7 | 2021 | 340 | 0.470 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2022 | 1138 | 0.470 |
Why?
| | Biota | 1 | 2013 | 35 | 0.440 |
Why?
| | B-Lymphocytes | 7 | 2022 | 772 | 0.440 |
Why?
| | Immunophenotyping | 9 | 2020 | 276 | 0.430 |
Why?
| | Bronchoalveolar Lavage Fluid | 9 | 2020 | 590 | 0.420 |
Why?
| | T-Lymphocytes | 9 | 2018 | 1747 | 0.420 |
Why?
| | Herpesviridae Infections | 4 | 2019 | 138 | 0.410 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 2 | 2009 | 18 | 0.410 |
Why?
| | Down-Regulation | 2 | 2016 | 599 | 0.380 |
Why?
| | Adult | 29 | 2020 | 30654 | 0.370 |
Why?
| | Interleukin-2 | 5 | 2013 | 415 | 0.370 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2019 | 487 | 0.360 |
Why?
| | Herpes Zoster | 4 | 2022 | 333 | 0.360 |
Why?
| | Herpesvirus 3, Human | 4 | 2022 | 380 | 0.350 |
Why?
| | Anti-Retroviral Agents | 3 | 2018 | 207 | 0.340 |
Why?
| | Middle Aged | 25 | 2020 | 26826 | 0.340 |
Why?
| | Male | 34 | 2022 | 55729 | 0.340 |
Why?
| | Gene Products, gag | 3 | 2016 | 36 | 0.330 |
Why?
| | Receptors, OX40 | 1 | 2009 | 15 | 0.330 |
Why?
| | Interleukin-10 | 4 | 2022 | 297 | 0.330 |
Why?
| | Antibodies, Viral | 4 | 2022 | 522 | 0.320 |
Why?
| | Membrane Proteins | 3 | 2013 | 1019 | 0.310 |
Why?
| | Chronic Disease | 9 | 2014 | 1591 | 0.300 |
Why?
| | Virus Activation | 3 | 2019 | 78 | 0.300 |
Why?
| | Immune System | 2 | 2019 | 172 | 0.300 |
Why?
| | Female | 33 | 2023 | 59610 | 0.300 |
Why?
| | Vaccination | 3 | 2021 | 1205 | 0.300 |
Why?
| | Dendritic Cells | 8 | 2019 | 436 | 0.290 |
Why?
| | Meningitis, Cryptococcal | 2 | 2020 | 28 | 0.290 |
Why?
| | Immunologic Factors | 2 | 2022 | 221 | 0.290 |
Why?
| | Cerebrospinal Fluid | 2 | 2020 | 90 | 0.290 |
Why?
| | Vitiligo | 2 | 2019 | 52 | 0.290 |
Why?
| | Sexual Behavior | 3 | 2020 | 440 | 0.280 |
Why?
| | Cohort Studies | 8 | 2019 | 4904 | 0.280 |
Why?
| | Interleukin-1 | 3 | 2019 | 970 | 0.270 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2010 | 618 | 0.270 |
Why?
| | Immunity, Innate | 3 | 2019 | 723 | 0.250 |
Why?
| | Gene Expression | 1 | 2010 | 1423 | 0.250 |
Why?
| | DNA, Bacterial | 2 | 2019 | 311 | 0.250 |
Why?
| | Animals | 25 | 2022 | 31867 | 0.230 |
Why?
| | Autoimmune Diseases | 2 | 2019 | 394 | 0.230 |
Why?
| | Interleukin-12 | 2 | 2022 | 110 | 0.230 |
Why?
| | Young Adult | 9 | 2020 | 10498 | 0.230 |
Why?
| | Fetomaternal Transfusion | 1 | 2023 | 10 | 0.220 |
Why?
| | Cell Proliferation | 8 | 2010 | 2191 | 0.220 |
Why?
| | Mice | 17 | 2021 | 14927 | 0.220 |
Why?
| | Interleukin-6 | 3 | 2022 | 676 | 0.220 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2022 | 29 | 0.210 |
Why?
| | Flow Cytometry | 9 | 2015 | 1084 | 0.210 |
Why?
| | Smokers | 2 | 2020 | 129 | 0.210 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 140 | 0.200 |
Why?
| | Peripheral Tolerance | 1 | 2022 | 14 | 0.200 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2022 | 154 | 0.200 |
Why?
| | HIV Core Protein p24 | 5 | 2010 | 28 | 0.200 |
Why?
| | Lymph Nodes | 3 | 2019 | 422 | 0.200 |
Why?
| | Killer Cells, Natural | 3 | 2014 | 383 | 0.200 |
Why?
| | Monocytes | 4 | 2019 | 503 | 0.190 |
Why?
| | Exanthema | 1 | 2022 | 76 | 0.190 |
Why?
| | Graft vs Host Disease | 1 | 2023 | 212 | 0.190 |
Why?
| | Chickenpox | 1 | 2022 | 93 | 0.190 |
Why?
| | Immunologic Memory | 6 | 2014 | 313 | 0.190 |
Why?
| | Macaca mulatta | 5 | 2022 | 131 | 0.180 |
Why?
| | Polysaccharides, Bacterial | 2 | 2022 | 66 | 0.180 |
Why?
| | Immunity, Humoral | 1 | 2021 | 112 | 0.180 |
Why?
| | Lung Diseases | 3 | 2017 | 703 | 0.180 |
Why?
| | Lymphocyte Depletion | 3 | 2019 | 116 | 0.180 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 4 | 2019 | 26 | 0.180 |
Why?
| | Melanoma, Experimental | 1 | 2021 | 89 | 0.180 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2021 | 56 | 0.180 |
Why?
| | Integrin alpha Chains | 1 | 2020 | 22 | 0.180 |
Why?
| | Pneumocystis | 2 | 1996 | 6 | 0.180 |
Why?
| | Genome, Bacterial | 1 | 2021 | 106 | 0.170 |
Why?
| | Cell Compartmentation | 1 | 2020 | 52 | 0.170 |
Why?
| | Haplotypes | 2 | 2019 | 455 | 0.170 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 144 | 0.170 |
Why?
| | Fetal Blood | 2 | 2014 | 270 | 0.170 |
Why?
| | Toll-Like Receptors | 2 | 2018 | 166 | 0.170 |
Why?
| | Cells, Cultured | 9 | 2016 | 3896 | 0.170 |
Why?
| | HLA-DR Antigens | 4 | 2016 | 220 | 0.160 |
Why?
| | CD4 Lymphocyte Count | 4 | 2013 | 257 | 0.160 |
Why?
| | Hexosaminidases | 1 | 2019 | 17 | 0.160 |
Why?
| | Audiovisual Aids | 1 | 2019 | 15 | 0.160 |
Why?
| | HLA-DQ Antigens | 2 | 2019 | 177 | 0.160 |
Why?
| | Multiple Myeloma | 1 | 2020 | 92 | 0.160 |
Why?
| | Pregnancy Complications | 1 | 2023 | 430 | 0.160 |
Why?
| | Prevotella | 1 | 2018 | 12 | 0.160 |
Why?
| | Aged | 11 | 2019 | 19119 | 0.160 |
Why?
| | Genes, MHC Class II | 1 | 2019 | 70 | 0.160 |
Why?
| | Disease | 1 | 2019 | 86 | 0.160 |
Why?
| | Emtricitabine | 2 | 2016 | 147 | 0.160 |
Why?
| | Virus Latency | 1 | 2019 | 80 | 0.150 |
Why?
| | Tenofovir | 2 | 2016 | 204 | 0.150 |
Why?
| | Monkey Diseases | 1 | 2018 | 19 | 0.150 |
Why?
| | Fluorescent Antibody Technique | 4 | 2015 | 396 | 0.150 |
Why?
| | Colony Count, Microbial | 1 | 2018 | 111 | 0.150 |
Why?
| | Colon | 1 | 2020 | 233 | 0.150 |
Why?
| | Green Fluorescent Proteins | 2 | 2018 | 373 | 0.150 |
Why?
| | Neoplasm Proteins | 1 | 2021 | 385 | 0.150 |
Why?
| | Cytotoxicity, Immunologic | 2 | 2015 | 196 | 0.150 |
Why?
| | CTLA-4 Antigen | 2 | 2019 | 78 | 0.150 |
Why?
| | Open Reading Frames | 1 | 2018 | 116 | 0.150 |
Why?
| | Pneumonia, Pneumocystis | 2 | 1996 | 26 | 0.150 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2018 | 80 | 0.150 |
Why?
| | Case-Control Studies | 7 | 2020 | 3015 | 0.150 |
Why?
| | Principal Component Analysis | 1 | 2018 | 176 | 0.150 |
Why?
| | Melanoma | 3 | 2008 | 622 | 0.140 |
Why?
| | In Vitro Techniques | 1 | 2019 | 1036 | 0.140 |
Why?
| | Skin | 2 | 2019 | 659 | 0.140 |
Why?
| | Mice, Knockout | 5 | 2021 | 2585 | 0.140 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 111 | 0.140 |
Why?
| | Vaccines, DNA | 1 | 2016 | 30 | 0.140 |
Why?
| | Genitalia | 1 | 2016 | 28 | 0.140 |
Why?
| | Immunization, Secondary | 1 | 2016 | 82 | 0.140 |
Why?
| | Antigen Presentation | 1 | 2017 | 189 | 0.130 |
Why?
| | Biopsy | 1 | 2020 | 1046 | 0.130 |
Why?
| | Withholding Treatment | 1 | 2016 | 69 | 0.130 |
Why?
| | Immune Tolerance | 2 | 2016 | 329 | 0.130 |
Why?
| | Hepatitis C | 2 | 2009 | 226 | 0.130 |
Why?
| | Mouth | 1 | 2015 | 68 | 0.130 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2016 | 353 | 0.130 |
Why?
| | Immune Evasion | 1 | 2015 | 47 | 0.130 |
Why?
| | Rectum | 1 | 2016 | 150 | 0.130 |
Why?
| | Retroviridae Infections | 1 | 2015 | 45 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2016 | 174 | 0.130 |
Why?
| | Software | 1 | 2019 | 537 | 0.130 |
Why?
| | Adolescent | 5 | 2020 | 17862 | 0.130 |
Why?
| | Survivors | 2 | 2016 | 410 | 0.120 |
Why?
| | Cytomegalovirus Infections | 2 | 2015 | 182 | 0.120 |
Why?
| | Transplantation, Homologous | 1 | 2016 | 390 | 0.120 |
Why?
| | Immunotherapy | 1 | 2019 | 474 | 0.120 |
Why?
| | Inflammation Mediators | 1 | 2018 | 476 | 0.120 |
Why?
| | Immune Reconstitution Inflammatory Syndrome | 1 | 2014 | 18 | 0.120 |
Why?
| | Macrophages | 4 | 2015 | 1267 | 0.120 |
Why?
| | Organophosphonates | 1 | 2015 | 90 | 0.120 |
Why?
| | Mortality | 1 | 2016 | 287 | 0.120 |
Why?
| | Biomarkers | 6 | 2019 | 3419 | 0.120 |
Why?
| | Deoxycytidine | 1 | 2015 | 138 | 0.120 |
Why?
| | Immunization | 2 | 2008 | 400 | 0.110 |
Why?
| | Physical Fitness | 1 | 2015 | 179 | 0.110 |
Why?
| | Receptors, Interleukin-1 | 1 | 2015 | 227 | 0.110 |
Why?
| | DNA, Ribosomal | 1 | 2013 | 80 | 0.110 |
Why?
| | Tropheryma | 1 | 2013 | 4 | 0.110 |
Why?
| | Whipple Disease | 1 | 2013 | 5 | 0.110 |
Why?
| | Adenine | 1 | 2015 | 220 | 0.110 |
Why?
| | Smoking | 1 | 2020 | 1392 | 0.110 |
Why?
| | Mice, Inbred BALB C | 3 | 2012 | 1153 | 0.110 |
Why?
| | Leukocyte Common Antigens | 3 | 2011 | 75 | 0.110 |
Why?
| | Galectins | 1 | 2013 | 22 | 0.110 |
Why?
| | Disease Models, Animal | 6 | 2019 | 3545 | 0.110 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2015 | 179 | 0.100 |
Why?
| | Hematopoiesis | 2 | 2011 | 172 | 0.100 |
Why?
| | 4-1BB Ligand | 2 | 2009 | 6 | 0.100 |
Why?
| | Prognosis | 2 | 2017 | 3334 | 0.100 |
Why?
| | Cytomegalovirus | 3 | 2015 | 145 | 0.100 |
Why?
| | Receptors, CXCR4 | 2 | 2010 | 78 | 0.100 |
Why?
| | Interleukins | 1 | 2013 | 236 | 0.100 |
Why?
| | Neovascularization, Pathologic | 1 | 2013 | 281 | 0.100 |
Why?
| | Sequence Analysis, DNA | 2 | 2013 | 728 | 0.100 |
Why?
| | RNA, Viral | 3 | 2004 | 567 | 0.100 |
Why?
| | Interleukin Receptor Common gamma Subunit | 1 | 2011 | 15 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 928 | 0.090 |
Why?
| | Th1 Cells | 2 | 2013 | 123 | 0.090 |
Why?
| | Cell Line | 5 | 2018 | 2645 | 0.090 |
Why?
| | Ecology | 1 | 2011 | 97 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2108 | 0.090 |
Why?
| | Motor Activity | 1 | 2015 | 642 | 0.090 |
Why?
| | CCR5 Receptor Antagonists | 1 | 2010 | 6 | 0.090 |
Why?
| | Metagenome | 1 | 2011 | 122 | 0.090 |
Why?
| | Lymphocyte Count | 4 | 2017 | 133 | 0.090 |
Why?
| | Ligands | 2 | 2014 | 565 | 0.090 |
Why?
| | Forkhead Transcription Factors | 2 | 2010 | 171 | 0.090 |
Why?
| | Skin Neoplasms | 2 | 2007 | 758 | 0.090 |
Why?
| | Molecular Sequence Data | 2 | 2013 | 2796 | 0.090 |
Why?
| | Hydroxamic Acids | 1 | 2010 | 80 | 0.090 |
Why?
| | Vagina | 1 | 2011 | 145 | 0.080 |
Why?
| | Antibodies, Monoclonal | 5 | 2020 | 1268 | 0.080 |
Why?
| | Risk Factors | 2 | 2020 | 8642 | 0.080 |
Why?
| | Cell Lineage | 1 | 2011 | 310 | 0.080 |
Why?
| | OX40 Ligand | 1 | 2009 | 10 | 0.080 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 2007 | 128 | 0.080 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2009 | 27 | 0.080 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 963 | 0.080 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 72 | 0.080 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2010 | 198 | 0.080 |
Why?
| | Myeloid Cells | 1 | 2009 | 127 | 0.080 |
Why?
| | Convalescence | 1 | 2007 | 15 | 0.070 |
Why?
| | Cell Division | 2 | 2013 | 758 | 0.070 |
Why?
| | Homeodomain Proteins | 1 | 2011 | 464 | 0.070 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 2329 | 0.070 |
Why?
| | Antibodies, Blocking | 1 | 2007 | 32 | 0.070 |
Why?
| | Genes, tat | 1 | 2007 | 2 | 0.070 |
Why?
| | Genes, rev | 1 | 2007 | 2 | 0.070 |
Why?
| | Arthritis, Experimental | 1 | 2009 | 132 | 0.070 |
Why?
| | Tumor Escape | 1 | 2007 | 35 | 0.070 |
Why?
| | Bronchoalveolar Lavage | 1 | 2007 | 84 | 0.070 |
Why?
| | Cystatins | 1 | 2006 | 7 | 0.070 |
Why?
| | Prospective Studies | 4 | 2016 | 6232 | 0.070 |
Why?
| | Ecosystem | 1 | 2011 | 517 | 0.070 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2006 | 97 | 0.070 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2007 | 92 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2009 | 1229 | 0.070 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2023 | 520 | 0.070 |
Why?
| | Signal Transduction | 4 | 2021 | 4525 | 0.070 |
Why?
| | RNA, Catalytic | 1 | 2007 | 182 | 0.070 |
Why?
| | Receptors, CCR7 | 1 | 2005 | 24 | 0.070 |
Why?
| | Interleukin-1beta | 2 | 2021 | 370 | 0.070 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2005 | 41 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2005 | 43 | 0.070 |
Why?
| | Hepacivirus | 1 | 2007 | 233 | 0.060 |
Why?
| | United States | 1 | 2021 | 12224 | 0.060 |
Why?
| | Neoplasms | 1 | 2019 | 2106 | 0.060 |
Why?
| | Hepatitis C, Chronic | 1 | 2007 | 152 | 0.060 |
Why?
| | Host-Pathogen Interactions | 2 | 2019 | 295 | 0.060 |
Why?
| | RNA, Small Interfering | 1 | 2007 | 541 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2019 | 4718 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2017 | 2201 | 0.060 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 2 | 2019 | 14 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2015 | 315 | 0.060 |
Why?
| | Antigens, CD34 | 3 | 2011 | 89 | 0.060 |
Why?
| | DNA-Binding Proteins | 2 | 2011 | 1318 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2019 | 817 | 0.060 |
Why?
| | Pulmonary Fibrosis | 1 | 2006 | 323 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2015 | 1700 | 0.050 |
Why?
| | CD4 Antigens | 3 | 2007 | 124 | 0.050 |
Why?
| | Immunoglobulin Isotypes | 1 | 2022 | 32 | 0.050 |
Why?
| | Immunoglobulin D | 1 | 2022 | 27 | 0.050 |
Why?
| | Bacteroides fragilis | 1 | 2022 | 11 | 0.050 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 2002 | 84 | 0.050 |
Why?
| | Lectins, C-Type | 1 | 2002 | 61 | 0.050 |
Why?
| | Longitudinal Studies | 3 | 2018 | 2389 | 0.050 |
Why?
| | Mice, SCID | 2 | 2007 | 319 | 0.050 |
Why?
| | Cell Count | 2 | 2016 | 304 | 0.050 |
Why?
| | Hypersensitivity | 1 | 2005 | 256 | 0.050 |
Why?
| | Allergens | 1 | 2005 | 417 | 0.050 |
Why?
| | Interferons | 1 | 2022 | 150 | 0.050 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 2 | 2003 | 309 | 0.050 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2002 | 218 | 0.050 |
Why?
| | CD28 Antigens | 2 | 2013 | 47 | 0.050 |
Why?
| | Phenotype | 3 | 2019 | 2815 | 0.050 |
Why?
| | Vaccines, Synthetic | 1 | 2021 | 125 | 0.050 |
Why?
| | Transforming Growth Factor beta | 3 | 2008 | 448 | 0.050 |
Why?
| | Species Specificity | 2 | 2016 | 548 | 0.050 |
Why?
| | Immunity | 1 | 2021 | 121 | 0.050 |
Why?
| | Arthritis, Rheumatoid | 1 | 2009 | 1002 | 0.040 |
Why?
| | Proteasome Inhibitors | 1 | 2020 | 40 | 0.040 |
Why?
| | Mice, Transgenic | 2 | 2019 | 1955 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2019 | 6357 | 0.040 |
Why?
| | Bacteroides | 1 | 2019 | 16 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2019 | 2563 | 0.040 |
Why?
| | B7-2 Antigen | 2 | 2013 | 25 | 0.040 |
Why?
| | Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1999 | 25 | 0.040 |
Why?
| | Genes, T-Cell Receptor beta | 1 | 1999 | 18 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 702 | 0.040 |
Why?
| | Survival Rate | 2 | 2017 | 1646 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2015 | 1634 | 0.040 |
Why?
| | Ganglia | 1 | 2019 | 29 | 0.040 |
Why?
| | Spondylarthritis | 1 | 2019 | 36 | 0.040 |
Why?
| | HLA-DQ beta-Chains | 1 | 2019 | 59 | 0.040 |
Why?
| | Coinfection | 1 | 2020 | 120 | 0.040 |
Why?
| | Macrophages, Peritoneal | 1 | 2019 | 91 | 0.040 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2010 | 66 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2019 | 98 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2019 | 201 | 0.040 |
Why?
| | Genetic Loci | 1 | 2019 | 264 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 398 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 186 | 0.040 |
Why?
| | Antigen-Presenting Cells | 1 | 2017 | 153 | 0.040 |
Why?
| | Cell Communication | 1 | 2018 | 280 | 0.030 |
Why?
| | Virus Diseases | 1 | 2019 | 196 | 0.030 |
Why?
| | Membrane Glycoproteins | 2 | 2013 | 429 | 0.030 |
Why?
| | Adventitia | 1 | 2016 | 37 | 0.030 |
Why?
| | Sheep | 1 | 1999 | 764 | 0.030 |
Why?
| | Life Style | 1 | 2018 | 431 | 0.030 |
Why?
| | Morbidity | 1 | 2017 | 279 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2019 | 5040 | 0.030 |
Why?
| | Spermatozoa | 1 | 2016 | 84 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2019 | 556 | 0.030 |
Why?
| | Viral Proteins | 1 | 2018 | 281 | 0.030 |
Why?
| | Virulence | 1 | 1996 | 228 | 0.030 |
Why?
| | Neuroglia | 1 | 2016 | 150 | 0.030 |
Why?
| | Retroviridae | 1 | 2015 | 90 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 797 | 0.030 |
Why?
| | Vero Cells | 1 | 2015 | 63 | 0.030 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2019 | 288 | 0.030 |
Why?
| | HIV Antigens | 1 | 2015 | 17 | 0.030 |
Why?
| | Immobilized Proteins | 1 | 2015 | 11 | 0.030 |
Why?
| | NF-kappa B | 1 | 2019 | 637 | 0.030 |
Why?
| | Neutralization Tests | 1 | 2015 | 63 | 0.030 |
Why?
| | Mice, Nude | 1 | 1996 | 631 | 0.030 |
Why?
| | Blood Cells | 1 | 2014 | 38 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2020 | 856 | 0.030 |
Why?
| | Autoantibodies | 1 | 2022 | 1354 | 0.030 |
Why?
| | Enhancer Elements, Genetic | 1 | 2016 | 152 | 0.030 |
Why?
| | Global Health | 1 | 2017 | 288 | 0.030 |
Why?
| | Safety | 1 | 2016 | 297 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2017 | 431 | 0.030 |
Why?
| | Lymphocyte Subsets | 1 | 2014 | 79 | 0.030 |
Why?
| | Extracellular Space | 1 | 2015 | 117 | 0.030 |
Why?
| | Endostatins | 1 | 2013 | 9 | 0.030 |
Why?
| | Endotoxemia | 1 | 2015 | 82 | 0.030 |
Why?
| | Activins | 1 | 2013 | 26 | 0.030 |
Why?
| | Colitis | 1 | 2016 | 226 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 262 | 0.030 |
Why?
| | Integrin alphaVbeta3 | 1 | 2013 | 20 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1780 | 0.030 |
Why?
| | Recurrence | 1 | 2016 | 941 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2013 | 47 | 0.030 |
Why?
| | B7-1 Antigen | 1 | 2013 | 54 | 0.030 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 103 | 0.030 |
Why?
| | DNA, Viral | 1 | 2015 | 349 | 0.030 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2013 | 119 | 0.030 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2013 | 89 | 0.030 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2013 | 35 | 0.030 |
Why?
| | Lymphokines | 1 | 2013 | 111 | 0.030 |
Why?
| | Muromegalovirus | 1 | 2013 | 13 | 0.030 |
Why?
| | Models, Immunological | 1 | 2013 | 92 | 0.030 |
Why?
| | Prednisone | 1 | 2014 | 231 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 190 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 791 | 0.030 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 154 | 0.030 |
Why?
| | Receptors, Virus | 1 | 2013 | 75 | 0.030 |
Why?
| | Interleukin-8 | 1 | 2013 | 238 | 0.030 |
Why?
| | Interleukin-15 | 1 | 2013 | 75 | 0.030 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 798 | 0.030 |
Why?
| | Fibroblasts | 1 | 2016 | 839 | 0.020 |
Why?
| | Severity of Illness Index | 2 | 2010 | 2551 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 5519 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1237 | 0.020 |
Why?
| | Peritoneum | 1 | 2011 | 36 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2015 | 776 | 0.020 |
Why?
| | Glioblastoma | 1 | 2013 | 253 | 0.020 |
Why?
| | Lymphoid Tissue | 1 | 2011 | 62 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2013 | 499 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2017 | 1085 | 0.020 |
Why?
| | Immunoglobulins | 1 | 2011 | 143 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2016 | 956 | 0.020 |
Why?
| | Smad3 Protein | 1 | 2010 | 41 | 0.020 |
Why?
| | Mucous Membrane | 1 | 2011 | 108 | 0.020 |
Why?
| | Valproic Acid | 1 | 2010 | 43 | 0.020 |
Why?
| | CD3 Complex | 1 | 2010 | 92 | 0.020 |
Why?
| | Antibody Formation | 1 | 2011 | 267 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2014 | 651 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2010 | 299 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2014 | 535 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2011 | 316 | 0.020 |
Why?
| | Radiation Chimera | 1 | 2009 | 31 | 0.020 |
Why?
| | Liver | 2 | 2007 | 1681 | 0.020 |
Why?
| | Radiation Injuries, Experimental | 1 | 2009 | 25 | 0.020 |
Why?
| | Mice, Inbred DBA | 1 | 2009 | 173 | 0.020 |
Why?
| | Glucocorticoid-Induced TNFR-Related Protein | 1 | 2008 | 5 | 0.020 |
Why?
| | Mutation | 1 | 2019 | 3350 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 1901 | 0.020 |
Why?
| | Bone Resorption | 1 | 2009 | 73 | 0.020 |
Why?
| | Alleles | 2 | 2003 | 792 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 1879 | 0.020 |
Why?
| | Research | 1 | 2011 | 395 | 0.020 |
Why?
| | Remission, Spontaneous | 1 | 2007 | 37 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2009 | 241 | 0.020 |
Why?
| | Precision Medicine | 1 | 2011 | 340 | 0.020 |
Why?
| | Toll-Like Receptor 2 | 1 | 2008 | 109 | 0.020 |
Why?
| | Interleukin-3 Receptor alpha Subunit | 1 | 2007 | 17 | 0.020 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 206 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2007 | 105 | 0.020 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2007 | 155 | 0.020 |
Why?
| | Transplantation Chimera | 1 | 2007 | 51 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 4631 | 0.020 |
Why?
| | Fibrosis | 1 | 2009 | 454 | 0.020 |
Why?
| | Blood | 1 | 2007 | 97 | 0.020 |
Why?
| | Cystatin C | 1 | 2006 | 62 | 0.020 |
Why?
| | CD8 Antigens | 1 | 2006 | 69 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2007 | 209 | 0.020 |
Why?
| | Gene Silencing | 1 | 2007 | 172 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2006 | 182 | 0.020 |
Why?
| | Bacillus subtilis | 1 | 2006 | 58 | 0.020 |
Why?
| | Time Factors | 1 | 2016 | 6141 | 0.020 |
Why?
| | Thymus Gland | 1 | 2007 | 296 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2007 | 291 | 0.020 |
Why?
| | Infant | 1 | 2019 | 7945 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2008 | 286 | 0.020 |
Why?
| | Immunity, Cellular | 1 | 2007 | 249 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2007 | 349 | 0.020 |
Why?
| | Child, Preschool | 1 | 2019 | 9093 | 0.020 |
Why?
| | Brain | 1 | 2016 | 2379 | 0.020 |
Why?
| | Apoptosis | 1 | 2013 | 2366 | 0.020 |
Why?
| | Aging | 1 | 2014 | 1624 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2007 | 1169 | 0.010 |
Why?
| | Hypertension, Pulmonary | 1 | 2013 | 1736 | 0.010 |
Why?
| | HLA-DRB1 Chains | 1 | 2003 | 98 | 0.010 |
Why?
| | Clone Cells | 1 | 2003 | 248 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2003 | 218 | 0.010 |
Why?
| | CD40 Antigens | 1 | 2002 | 82 | 0.010 |
Why?
| | Child | 1 | 2019 | 18407 | 0.010 |
Why?
| | Consensus Sequence | 1 | 1999 | 70 | 0.010 |
Why?
| | Germ Cells | 1 | 1999 | 57 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1999 | 257 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1999 | 325 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 353 | 0.010 |
Why?
| | Disease Progression | 1 | 2005 | 2389 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1999 | 524 | 0.010 |
Why?
| | Protein Binding | 1 | 2003 | 1898 | 0.010 |
Why?
| | Opportunistic Infections | 1 | 1996 | 43 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1999 | 999 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1999 | 617 | 0.010 |
Why?
| | Base Sequence | 1 | 1999 | 2119 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1999 | 1990 | 0.010 |
Why?
| | Genetic Variation | 1 | 1999 | 876 | 0.010 |
Why?
|
|
Palmer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|